Angion Biomedica Company
Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Founded Date:
1998
Last Funding Date:
2021
Employee Number:
11-50
Investors Number:
2
Technology:
Data-driven Technologies
Last Funding Type:
Post-IPO Equity
Investor Type:
IPO
Headquarters:
Uniondale, New York, United States
Total Funding:
44356452
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Biopharma, Biotechnology, Medical